This funding opportunity from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health (NIH), invites applications for ancillary studies that leverage the resources (such as well-characterized patient cohorts, infrastructure, data, and biological samples) of ongoing parent clinical studies. While the parent studies may be outside the NIAMS mission, the proposed ancillary study must align with and address the NIAMS mission. R01 clinical trial applications are explicitly not allowed. The opportunity encourages collaborative investigations and welcomes investigators with expertise in NIAMS-related diseases and conditions.
This funding opportunity from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health (NIH), invites applications for ancillary studies that leverage the resources (such as well-characterized patient cohorts, infrastructure, data, and biological samples) of ongoing parent clinical studies. While the parent studies may be outside the NIAMS mission, the proposed ancillary study must align with and address the NIAMS mission. R01 clinical trial applications are explicitly not allowed. The opportunity encourages collaborative investigations and welcomes investigators with expertise in NIAMS-related diseases and conditions.